BRIEF-Redhill Biopharma and Intelgenx enters into an agreement for commercialization of Rizaport

* Redhill, Intelgenx expect to re-submit Rizaport U.S. New

drug application to FDA in H1 2017, subsequently receive a new

PDUFA date

Read more